HealthKois Launches $300 Mn Fund to Back Early Growth-Stage Healthtech Start-Ups

A new healthcare investment fund, Healthkois, has been launched with a target corpus of $300 million, and an additional green shoe option of $100 million. The fund was set up by the founding team of HealthQuad --- Charles Janssen, Ajay Mahipal, and Dr Pinak Shrikhande.

It will invest between $7 million to $25 million per company in early growth-stage businesses operating across healthtech HealthTech, Life Sciences, MedTech, Healthcare Delivery and Climate Health. It is focussed on supporting companies that offer robust operational scalability, demonstrable clinical outcomes, and sustainable infrastructure solutions.

“HealthKois will back technology-led and innovative healthcare companies that address critical gaps in accessibility, affordability, and quality of care. Our goal is to transform care delivery by enabling early-growth ventures that bring real-world impact,” said Charles Janssen, Managing Partner, HealthKois.

“With access to over 75% proprietary deal flow, we’re well-positioned to leverage our deep networks and operational expertise to deliver both superior financial returns and societal outcomes,” he added.

HealthKois serves as a long-term partner, driving growth, enabling market expansion, and fostering value creation at every stage. It is aligned with the UN’s Sustainable Development Goal #3 and compliant with Article 9 of the EU Sustainable Finance Disclosure Regulation.

Speaking about the fund, Ajay Mahipal, Partner at HealthKois said, “We are long-term collaborators with founders, bringing strategic direction, global networks, and deep sector knowledge to help unlock their full potential. We invest in ventures that revolutionise healthcare delivery while also strengthening infrastructure resilience in India and other LMIC markets.”

Another partner, Dr Piinak Shrikhande said the team looks for companies that go beyond intent to deliver real clinical and operational impact. “Transformation doesn’t happen in silos, it requires a blend of clinical insight, practical know-how, and the conviction to back bold ideas.”

The fund has been built upon the legacy of HealthQuad Funds I and II, which have backed companies having touched over 90 million lives and serve 8.2 million patients annually. HealthQuad Funds I and II will continue to operate under the existing framework.